This item is authorised by the following title:
Disallowed in Part
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2018 (No. 1) (PB 27 of 2018)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2016 (No. 1) (PB 24 of 2016)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2015 (No. 1) (PB 99 of 2015)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2014 (No. 2) (PB 80 of 2014)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2014 (No. 1) (No. PB 23 of 2014)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 4) (No. PB 77 of 2013)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 3) (PB No. 47 2013)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 2) (No. PB 7 of 2013)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 1) (No. PB 6 of 2013)
National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2012 (No. 2) (No. PB 80 of 2012)
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2012 (No. 1) (No. PB 16 of 2012)
Disallowed in Part